| 000 | 01826nam a2200397 i 4500 | ||
|---|---|---|---|
| 999 |
_c256276 _d256276 |
||
| 001 | ocn959497285 | ||
| 003 | BD | ||
| 005 | 20171107200444.0 | ||
| 007 | he bmb024bbca | ||
| 008 | 160928m20169999dcu eb f000 0 eng c | ||
| 040 |
_aPUCPR _beng _erda _cJJG _dOCLCO _dGPO |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 049 | _aBDDF | ||
| 050 | 1 | 4 |
_aKF32 _b.E55 2016 |
| 074 | _a1008-D (MF) | ||
| 086 | 0 | _aY 1.1/8:114-561/ | |
| 099 | _aY 1.1/8:114-561/ | ||
| 110 | 1 |
_aUnited States. _bCongress. _bHouse. _bCommittee on Energy and Commerce, _eauthor. |
|
| 245 | 1 | 0 |
_aOpioid Use Disorder Treatment Expansion and Modernization Act : _breport (to accompany H.R. 4981). |
| 264 | 1 |
_a[Washington, D.C.] : _b[U.S. Government Publishing Office], _c[2016]- |
|
| 300 |
_avolumes ; _c24 cm. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_amicroform _bh _2rdamedia |
||
| 338 |
_amicrofiche _bhe _2rdacarrier |
||
| 490 | 1 |
_aRept. / 114th Congress, 2d session, House of Representatives ; _v114-561 |
|
| 500 | _a"May 10, 2016"--Pt. 1. | ||
| 500 | _aShipping list no.: 2016-0190-M (pt. 1). | ||
| 500 | _aCRDP Project record. | ||
| 533 |
_aMicrofiche. _b[Washington, D.C.] : _cU.S. Government Printing Office, _d[2016]- _emicrofiches : negative. |
||
| 650 | 0 |
_aOpioid abuse _xLaw and legislation _zUnited States. |
|
| 650 | 0 |
_aDrug abuse _xTreatment _xLaw and legislation _zUnited States. |
|
| 655 | 7 |
_aLegislative materials. _2lcgft |
|
| 776 | 0 | 8 |
_iPrint version: _aUnited States. Congress. House. Committee on Energy and Commerce. _tOpioid Use Disorder Treatment Expansion and Modernization Act _w(OCoLC)950264051 |
| 776 | 0 | 8 |
_iOnline version: _aUnited States. Congress. House. Committee on Energy and Commerce. _tOpioid Use Disorder Treatment Expansion and Modernization Act _w(OCoLC)949684181 |
| 810 | 1 |
_aUnited States. _bCongress. _bHouse. _tReport ; _v114-561. |
|
| 942 |
_2sudocs _c12 |
||